新曙光
對疾病的早期攔截
專題稿


MiRXES announced today that Dr. Lihan ZHOU, Co-founder and Chief Executive Officer at MiRXES, Dr. Ruiyang ZOU, Co-founder and Chief Technology Officer at MiRXES and Mr. Isaac HO, Chief Investment Officer at MiRXES, have been named EY Entrepreneur Of The Year (EOY) 2021 Singapore by professional services organization, EY.
Learn More

At-home cancer tests that could detect the disease even in the absence of symptoms? They could very well be a possibility in the future.
Dr Zhou is the Chief Executive Officer of MiRXES, a biotechnology company he co-founded with Chief Technology Officer Dr Zou Ruiyang, that specialises in producing polymerase chain reaction (PCR) tests to detect early stage cancer. The company brings to life his vision, running with the ethos that prevention is better than cure, and that early detection enables early interception, leading to early treatment and subsequently, saved and improved lives.


Whenever we fall sick, we often associate each illness with a characteristic set of symptoms. Constantly sneezing with a bad rash? Must be allergies. Stuffy nose and sore throat? Likely the flu. Bloodshot eyes? Likely conjunctivitis or pink eye. But not all diseases come with obvious symptoms.
交付我們的解決方案
在當今世界,每 4 個人中就有 1 人患有癌症。MiRXES 深知科學在抗擊癌症中的重要性。
我們清楚,要發揮最大影響力改善和挽救生命,必須將我們的創新解決方案從實驗室轉到臨床上。
閱讀關於我們解決方案方面的更多內容,包括領先行業的發現工具和服務:它們涵蓋對癌症、心血管疾病、代謝疾病和傳染病的診斷檢測,以及精準的腫瘤學知識。這些能夠幫助您在至關重要的時刻儘快採取行動。
